Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Torrent Pharmaceuticals Ltd ( (IN:TORNTPHARM) ) is now available.
Torrent Pharmaceuticals has called a court-convened general meeting of its equity shareholders on April 28, 2026, to be held via video conferencing as directed by the National Company Law Tribunal, Ahmedabad bench. Shareholders will be able to cast their votes remotely between April 24 and April 27, with an additional e-voting window during the meeting for those who have not voted earlier.
The meeting will consider a proposed Scheme of Amalgamation under Sections 230 and 232 of the Companies Act, through which J. B. Chemicals & Pharmaceuticals will be merged into Torrent Pharmaceuticals. Extensive supporting documents, including valuation reports, fairness opinions, financial statements, regulatory observation letters, and complaint reports, indicate the transaction is at an advanced stage of regulatory and procedural review, with potential implications for Torrent’s scale and position in the pharmaceutical market if approved by shareholders and authorities.
More about Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd is an India-based pharmaceutical company focused on developing, manufacturing, and marketing branded and generic medicines. It operates across key therapeutic areas and serves domestic and international markets, positioning itself as a prominent player in the Indian pharma sector.
Average Trading Volume: 9,393
Technical Sentiment Signal: Buy
Current Market Cap: 1454.1B INR
For a thorough assessment of TORNTPHARM stock, go to TipRanks’ Stock Analysis page.